Company / SG&A Expense
ICU Medical SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$625.2M
FY2025
5-year range
$277.0M / $638.8M
FY2021-FY2025
Trend
-2.1%
vs FY2024
Sector context
#59 of 158
Health Care
What the data says
At $625M, ICU Medical's sg&a expense ranks #100 of 158 in the Health Care sector. SG&A Expense has fluctuated over the past 10 years, ranging from $83M in FY2017 to $639M in FY2024.
Based on SEC 10-K filings.
$625M in FY2025 with a 5-year CAGR of +14.3%.
Increased from $607M to $625M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +30.1%
- 5-Year CAGR
- +14.3%
- 10-Year CAGR
- -
Sector benchmark
#100 of 158 in Health CareTop 63% of 158This company $625.2M Sector average $175.9B
▼
-99.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.3%, indicating consistent growth.
- In FY2025, sg&a expense decreased 2.1% year-over-year.
- Ranks #59 out of 158 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $625.2M | -2.1% |
| FY2024 | $638.8M | +5.3% |
| FY2023 | $606.7M | +113.7% |
| FY2022 | $284.0M | +2.5% |
| FY2021 | $277.0M | -13.4% |
| FY2020 | $320.0M | +5.9% |
| FY2019 | $302.2M | +237.9% |
| FY2018 | $89.4M | +7.5% |
| FY2017 | $83.2M | -6.4% |
| FY2016 | $88.9M | -0.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026